Search
aTyr Pharma Inc
ATYRAdd to Watchlist
0.375USD
+0.019+5.34%
Close 09-23 16:00（ET）
36.77MMarket Cap
LossP/E TTM
aTyr Pharma Inc (ATYR) Stock Price Target & Forecast
Analyst Rating
Based on 9 analysts giving stock ratings to aTyr Pharma Inc in the past month.
Buy
1 Strong Buy
3 Buy
5 Hold
0 Sell
0 Strong Sell
Target Price
2.833USD+694.99%
ATYR Analyst Recommendation Trends
In the current month, ATYR has received 3 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. ATYR average Analyst price target in the last month is 2.833.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
1
1
1
1
1
1
1
1
3
3
2
2
2
2
2
2
5
5
7
7
7
7
7
7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9
9
10
10
10
10
10
10
ATYR Analyst Rating for Peer Comparison
Updated: Sep 23, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
argenx SE
ARGX
10
13
3
0
0
26
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, ATYR EPS is projected to reach -0.100 in FY2026Q3, following reported EPS of -0.105 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.18
-0.14
-0.12
-0.10
-0.09
Actual
-0.14
-0.11
-0.11
--
--
Surprise
+22.51%
+19.96%
+13.43%
--
--
FAQs
What is aTyr Pharma Inc's price target?
Analysts forecast that aTyr Pharma Inc's price target is USD 2.83, with the highest forecast at USD 7.00 and the lowest forecast at USD 1.00.
How have aTyr Pharma IncATYR's recent earnings per share performed?
The market expectation was USD -0.11, while aTyr Pharma IncATYR's earnings per share (EPS) for the previous quarter was USD -0.11. EPS for the next quarter is expected at USD -0.10.
What is the analyst rating for aTyr Pharma Inc?
Based on the ratings of aTyr Pharma Inc's stock from 9 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.